Corcept Therapeutics | CORT - Sales Revenues

Corcept Therapeutics reported $101.73M in Sales Revenues for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Sales Change
Ani Pharmaceuticals ANIP:US USD 94.23M 10.41M
Aurora Cannabis Inc ACB:CN CAD 61.68M 12.42M
Bristol Myers Squibb BMY:US USD 11.41B 188M
Canopy Growth Corp WEED:CN CAD 101.21M 16.65M
Eli Lilly And LLY:US USD 7.3B 360.2M
Esperion Therapeutics ESPR:US USD 18.82M 162K
Johnson & Johnson JNJ:US USD 23.71B 85M
Knight Therapeutics Inc GUD:CN CAD 72.28M 3.54M
Lannett LCI:US USD 80.89M 5.82M
Merk MRK:US USD 13.83B 1.13B
Novartis NOVN:VX USD 13B 159M
Novartis NVS:US USD 13B 159M
Pfizer PFE:US USD 24.29B 1.65B